Barely Significant
← all excerpts

Stroke Prevention in Atrial Fibrillation: Where are We Now?

Clin Med Insights Cardiol · 2012 · PMC3296491 · PMID 22408371

Europe PMCDOI
2
hedged sentences
0.1170
closest p · 2.3× alpha
0.1170
boldest claim

The sentences

did not reach statistical significanceP = 0.117not close (p > 0.1)
The stricter intention-to-treat analysis also showed rivaroxaban was similar to warfarin but did not reach statistical significance for superiority: event rate 2.12 versus 2.42 per 100 patient years for rivaroxaban versus warfarin; HR 0.88, 95% CI 0.74–1.03, P = 0.117 for superiority.

also in 111,027 other papers

approached significanceno p-value reported
There was, however, a numeric decrease in both dabigatran groups that approached significance for those receiving dabigatran 150 mg.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.